Table 4.
The results of subgroup analysis in prevalence of depression in sarcopenia
| Outcomes | Numbers of studies | Meta‐analysis results | I 2 (%) | P |
|---|---|---|---|---|
| Diagnostic criteria for sarcopenia | ||||
| AWGS | 6 | 0.31 (0.20–0.43) | 89.4 | <0.001 |
| EWGSOP | 6 | 0.29 (0.18–0.39) | 92.5 | <0.001 |
| FNIH | 1 | 0.09 (0.04–0.14) | / | / |
| Measurement method for LMM | ||||
| BIA | 9 | 0.32 (0.22–0.41) | 93.4 | <0.001 |
| DEXA | 2 | 0.12 (0.07–0.17) | 36.8 | 0.208 |
| Calf circumference | 1 | 0.32 (0.18–0.47) | / | / |
| Mid‐arm muscle circumference | 1 | 0.30 (0.19–0.41) | / | / |
| Measurement method for depression | ||||
| GDS‐15 | 8 | 0.28 (0.20–0.36) | 91.1 | <0.001 |
| GDS | 1 | 0.64 (0.51–0.77) | / | / |
| CISR‐B | 1 | 0.09 (0.04–0.14) | / | / |
| CES‐D | 1 | 0.08 (0.00–0.16) | / | / |
| SDS | 1 | 0.40 (0.22–0.58) | / | / |
| DSM | 1 | 0.30 (0.19–0.41) | / | / |
| BMI | ||||
| Overweight | 2 | 0.36 (−0.18–0.90) | 98.3 | <0.001 |
| Normal | 9 | 0.29 (0.20–0.38) | 90.0 | <0.001 |
| Unknown | 2 | 0.22 (0.08–0.36) | 85.3 | 0.001 |
| Ethnicity | ||||
| Asia | 10 | 0.32 (0.22–0.41) | 92.2 | <0.001 |
| America | 2 | 0.11 (0.07–0.16) | 50.7 | 0.154 |
| Europe | 1 | 0.30 (0.19–0.41) | / | / |
| Site | ||||
| Community | 12 | 0.27 (0.20–0.35) | 91.9 | <0.001 |
| Clinic | 1 | 0.41 (0.31–0.51) | / | / |
Abbreviations: BIA, bioelectrical impedance analysis; DEXA, dual‐energy X‐ray absorptiometry; GDS, Geriatric Depression Scale; GDS‐15, 15‐item Geriatric Depression Scale; CES‐D, Center for Epidemiologic Studies Depression Scale; SDS, Self‐rating Depression Scale; CISR‐B, Brazilian version of the Clinical Interview Scheduled Revised; DSM, Diagnostic and Statistical Manual of Mental Disorders.